Glenmark gets US FDA nod for skin cream Kenalog generic
Glenmark Pharmaceuticals has received final nod from the US health regulator for generic Triamcinolone acetonide cream used for reducing itching, redness and swelling on skin. The company's US subs... Glenmark Pharmaceuticals receives ANDA approval for Triamcinolone Acetonide Cream USP, 0.1%
Glenmark Pharmaceuticals Ltd has informed BSE regarding a Press Release dated August 08, 2016 titled "Glenmark Pharmaceuticals receives ANDA approval for Triamcinolone Acetonide Cream USP, 0.1%". Sell Glenmark Pharmaceuticals, target Rs 785: Reliance Securities
Sell Glenmark Pharmaceuticals Ltd. at a price target of Rs 785 and a stop loss at Rs 893 Q1 results on August 12, 2016
Glenmark Pharmaceuticals Ltd has informed BSE that a meeting of the Board of Directors will be held on August 12, 2016 to consider and approve the Company's Unaudited Financial Statements for the First Quarter ended June 30, 2016 (Q1).Further, as per the "Code of Conduct for Prevention of Insider Trading" of the Company, the trading window closed for Directors and other designated employees of the Company on June 25, 2016 and will remain... Buy Glenmark Pharmaceuticals, target Rs 910: Siddarth Bhamre
Buy Glenmark Pharmaceuticals Ltd. at a price target of Rs 910.0 and a stop loss at Rs 824 Glenmark gets USFDA nod for potassium chloride tablets
Glenmark Pharmaceuticals has received final approval from the US health regulator for Potassium Chloride Extended Release Tablets, used for treating low levels of potassium in blood. Glenmark Phar... Glenmark Pharmaceuticals receives ANDA approval for Potassium Chloride Extended-Release Tablets USP, 10 mEq (750 mg) and 20 mEq (1500 mg)
Glenmark Pharmaceuticals Ltd has informed BSE regarding a Press Release dated July 27, 2016 titled "Glenmark Pharmaceuticals receives ANDA approval for Potassium Chloride Extended-Release Tablets USP, 10 mEq (750 mg) and 20 mEq (1500 mg)". Glenmark Pharmaceuticals announces the successful closure of its USD 200 mn Reg S USD Bond
Glenmark Pharmaceuticals Ltd has informed BSE that the Company has announces the successful closure of its USD 200 mn Reg S USD Bond. The bond was oversubscribed 8 times.
Glenmark gets USFDA nod to launch ointment to treat eczema in US
Glenmark said the US FDA has granted it final approval to launch an ointment for specific skin conditions in the US Glenmark Pharmaceuticals receives ANDA approval for Triamcinolone Acetonide Ointment USP, 0.5%
Glenmark Pharmaceuticals Ltd has submitted to BSE a copy of Press Release dated July 25, 2016 titled ''Glenmark Pharmaceuticals receives ANDA approval for Triamcinolone Acetonide Ointment USP, 0.5%".